Live tape
Top 8, mentions 7d10,702GOOGL2,044 mentions▲ +0.04SNDK1,514 mentions▲ +0.11SPCX1,492 mentions▲ +0.08NBIS1,419 mentions▲ +0.09HTZ1,232 mentions▲ +0.10NVDA1,177 mentions▲ +0.08META991 mentions▲ +0.03MSFT833 mentions▲ +0.06

Equity · Consumer Cyclical

MNRO

Monro, Inc. · NasdaqGS

$17 −2.58% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 40 sessions
$18 $14 20 May 17 Jul

The line runs $16 on 20 May through $17 on 17 July, on a scale from $14 to $18. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of MNRO over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 40 sessions over that window: $16 on 20 May 2026 through $17 on 17 July 2026.

Market cap $510.4M
P/E (TTM) 42.5
52-week range $13 – $23.79
Avg volume 202.3K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

MNRO insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 11 Aug 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 3

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
11 Aug 2026 MELLOR ROBERT E Director Award 11,149
18 Jun 2026 SOLOMON PETER J Director Other 19,664
18 Jun 2026 SOLOMON PETER J Director Award 1,204,908

MNRO reported financials

SEC EDGAR XBRL

MNRO reported revenue of $1.2B for the fiscal year ended 28 Mar 2026. Net income over the same period was $2.2M.

Figure Reported Period
Revenue $1.2B 28 Mar 2026 fiscal year
Net income $2.2M 28 Mar 2026 fiscal year
Diluted EPS $0.03 28 Mar 2026 fiscal year
Total assets $1.6B 28 Mar 2026 at period end
Total equity incl. minority interest $591.5M 28 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 28 Mar 2026

MNRO earnings

SEC EDGAR
Date Period EPS Revenue
28 Mar 2026 FY 2026 $0.03 $1.16B
27 Dec 2025 Q3 2026 $0.35 $293M
27 Sep 2025 Q2 2026 $0.18 $289M
28 Jun 2025 Q1 2026 $-0.28 $301M
29 Mar 2025 FY 2025 $-0.22 $1.20B
28 Dec 2024 Q3 2025 $0.15 $306M
28 Sep 2024 Q2 2025 $0.18 $301M
29 Jun 2024 Q1 2025 $0.19 $293M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

MNRO institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a MNRO position for the quarter ended 30 Jun 2026 — a combined $156.7M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Carl Icahn Held (±25%) 5,078,573 $86.9M
GAMCO Investors Held (±25%) +8.9% shares 2,740,858 $46.9M
Two Sigma Investments Held (±25%) +24.2% shares 462,650 $7.9M
Millennium Management New position 329,316 $5.6M
AQR Capital Management Trimmed −40.7% shares 194,222 $3.3M
Citadel Advisors Held (±25%) +5.0% shares 163,187 $2.8M
Renaissance Technologies New position 103,679 $1.8M
D. E. Shaw & Co. Added +34.4% shares 66,766 $1.1M
Marshall Wace Trimmed −88.8% shares 20,421 $349K

Source: SEC EDGAR 13F filings

MNRO fails-to-deliver

SEC CNS data

On 27 Jul 2026, 7,288 shares of MNRO failed to deliver (about $122K) — the latest of 3 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
27 Jul 2026 7,288 $122K 0.024%
24 Jul 2026 3,649 $61K 0.012%
23 Jul 2026 3,212 $54K 0.011%
21 Jul 2026 1,699 $29K 0.006%
16 Jul 2026 94 $2K <0.001%

Source: SEC fails-to-deliver (CNS) data